Down 30% This Year, Is Truist a Buy Before 2023?
Truist is the byproduct of the larger merger between SunTrust and BB&T.
BJ’s Wholesale Stock Continues to Crush the Market. Is Now the Time to Buy?
The Costco competitor just posted its most profitable third quarter ever.
Down 52%, Amazon Stock Is a Once-in-a-Decade Buying Opportunity Before 2023
Amazon has struggled this year, but patient investors have good reason to be bullish about the tech titan’s future.
3 Stocks to Avoid This Week
These investments seem pretty vulnerable right now.
This Irreplaceable REIT Just Raised Rents 83%
This industrial REIT owns key properties in a huge market. And it’s not going anywhere.
Why Tomorrow Could Be a Huge Day for the Stock Market
New inflation data is due out in the morning, and the Federal Reserve’s final meeting of the year kicks off.
This Stock-Split Stock Sees Unstoppable Growth Ahead
The company’s strategy has its growth already locked in for the next few years.
This Could Be the Most Dangerous Social Security Myth You’ll Ever Come Across
It has the potential to leave you utterly cash-strapped in retirement.
Don’t Invest in Stocks Unless You Can Answer This Question
It requires a closer look at one’s own personality and strengths.
1 Underground Stock to Grow Crops and Your Portfolio
This stock crushed the market in 2022. And you likely have never heard of it.
Here Are the 5 Big Moves Warren Buffett Made in 2022
Warren Buffett made five big buys this year, showing an affinity for energy and tech.
Good News for Retired Workers: The Monster Social Security COLA in 2023 Keeps Looking Better
Retired workers on Social Security should be thrilled to see inflation decelerating.
Could insulin come in a pill? How a molecule that mimics insulin may advance diabetes research
Researchers have answered a 100-year-old question in diabetes research: can a molecule different to insulin have the same effect? The findings provide important insights for the future development of an oral insulin pill.